Anemia drugs Flashcards

1
Q

Iron Preparation drugs

A
For microcytic anemia
Ferrous sulfate
Ferrous gluconate
Ferrous Fumarate
Iron dextran
iron sucrose
Sodium-ferric gluconate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ferrous sulfate, ferrous gluconate, ferrous fumarate description

A

Oral iron therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ferrous sulfate, ferrous gluconate, ferrous fumarate pharmacodynamics

A

works just as good as parenteral if absorption is normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ferrous sulfate, ferrous gluconate, ferrous fumarate indication

A

iron deficient anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ferrous sulfate, ferrous gluconate, ferrous fumarate adverse

A

GI: Constipation, dark stools, cramps, vomiting, diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Iron dextran, iron sucrose, Sodium-ferric gluconate description

A

parenteral iron therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Iron dextran, iron sucrose, sodium-ferric gluconate pharmacodynamics

A

Toxicity is very rare; mostly occurs in young children after accidental ingestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Iron dextran, iron sucrose, sodium-ferric gluconate indication

A

Patients who do not tolerate or absorb iron well

Extensive anemia that cannot be maintained on oral iron alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Iron dextran, iron sucrose, sodium-ferric gluconate adverse

A

Acute iron toxicity -> necrotizing gastroenteritis with vomiting, abdominal pain, bloody diarrhea (-> possibly shock, metabolic acidosis, coma and death)
Treat-> deferoxamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Iron chelator drugs

A

Deferoxamine

Deferasirox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Iron chelator description

A

Phlebotomy-for chronic iron overload without anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Iron chelator pharmacodynamics

A

Binds absorbed iron and promotes excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Iron chelator indication

A

Chronic iron toxicity:

Hemochromatosis or multiple transfusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vitamin B12 aka Cyanocobalamin
Hydroxycobalamin
Description

A

For macrocytic anemia

Parenteral (huge body stores take a long time to deplete)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vitamin B12, cyanocobalamin, hydroxycobalamin pharmacodynamics

A

Two reactions:
homocysteine -> methionine
methyl-malonyl -> succinyl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Vitamin B12, cyanocobalamin, hydroxycobalamin indication

A

Malabsorption of Vit B12 (loss of IF,etc)

Can be partly correct with folic acid

17
Q

Vitamin B12, cyanocobalamin, hydroxycobalamin adverse

A

Deficiency of cobalamin can cause neurologic abnormalities due to increased homocysteine

18
Q

Folic acid description

A

macrocytic anemia

Deficiency is a lot more common than B12 but can be easily corrected

19
Q

Folic acid pharmacodynamics

A

required for purine synthesis

Need B12 to for THF -> folate trap

20
Q

Folic acid indication

A
Folate deficiency (1-6 months to develop) can cause congenital malformation and vascular disease
Drug induced: MTX, trimethoprim, pyrimethamine (inhibit DHF reductase)
21
Q

Folic acid adverse

A

Masking of neurologic deficits in B12 deficiency

22
Q

Erythropoietin description

A

stimulates erythroid proliferation (JAK/STAT)

23
Q

Erythropoietin pharmacodynamics

A

produced in the kidney in response to hypoxia

24
Q

Erythropoietin indication

A

Anemia with renal disease (can’t produce endogenous EPO -> best responders)

25
Darbepoetin description
3x longer acting than EPO | -Two CHO chains
26
Darbepoetin indications
chronic anemia with renal failure | Myelosuppressive chemotherapy
27
Erythropoietin and Darbepoetin adverse
Hyperviscosity -> HTN and thrombosis
28
Filgrastim and Sargramostim description
Myeloid growth factors with JAK/STAT receptors
29
FIlgrastim and Sargramostim pharmacodynamics
proliferation and differentiation of PMN's
30
Filgrastim and Sargramostim indication
Neutropenia (1 or 2 degree) | Chemotherapy
31
IL-11 description
Megakaryocyte growth factor
32
IL-11 pharmacodynamics
Increases platelets
33
IL-11 Indications
Hx of thromboycytopenia with chemo; decreases need for platelet transfusion
34
Hydroxyurea description
Relieves painful course of sickle cell disease
35
Hydroxyurea pharmacodynamics
Increases HbF concentration
36
Hydroxyurea indication
Sickle cell anemia
37
Hydroxyurea Adverse
BM suppression | Cutaneous vasculitis